ERYTHROMYCIN tablet

Država: Združene države Amerike

Jezik: angleščina

Source: NLM (National Library of Medicine)

Aktivna sestavina:

ERYTHROMYCIN (UNII: 63937KV33D) (ERYTHROMYCIN - UNII:63937KV33D)

Dostopno od:

AbbVie Inc.

INN (mednarodno ime):

ERYTHROMYCIN

Sestava:

ERYTHROMYCIN 333 mg

Tip zastaranja:

PRESCRIPTION DRUG

Status dovoljenje:

APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT

Lastnosti izdelka

ERYTHROMYCIN- ERYTHROMYCIN TABLET
ABBVIE INC.
----------
ERYTHROMYCIN
PRINCIPAL DISPLAY PANEL - 333 MG TABLET BOTTLE LABEL
NDC 24338-112-60
60 Tablets
PCE
333 MG
TABLETS
ERYTHROMYCIN
PARTICLES
IN TABLETS
RX ONLY
ARBOR™
PHARMACEUTICALS, LLC.
PRINCIPAL DISPLAY PANEL - 500 MG TABLET BOTTLE LABEL
NDC 24338-114-13
100 Tablets
_PCE_
_500 mg_
_TABLETS_
®
®
_erythromycin_
_particles in tablets_
RX ONLY
ARBOR™
PHARMACEUTICALS, LLC.
ERYTHROMYCIN
erythromycin tablet
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:0 0 51-6 29 0
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
ERYTHRO MYCIN (UNII: 6 39 37KV33D) (ERYTHROMYCIN - UNII:6 39 37KV33D)
ERYTHROMYCIN
333 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
PO WDERED CELLULO SE (UNII: SMD1X3XO9 M)
CITRIC A CID MO NO HYDRA TE (UNII: 29 6 8 PHW8 QP)
SILICO N DIO XIDE (UNII: ETJ7Z6 XBU4)
D&C RED NO . 3 0 (UNII: 2S42T28 0 8 B)
LA CTO SE (UNII: J2B2A4N9 8 G)
MA G NESIUM STEA RA TE (UNII: 70 0 9 7M6 I30 )
CELLULO SE, MICRO CRYSTA LLINE (UNII: OP1R32D6 1U)
PO VIDO NES (UNII: FZ9 8 9 GH9 4E)
PRO PYLENE G LYCO L (UNII: 6 DC9 Q16 7V3)
SO DIUM STA RCH G LYCO LA TE TYPE A CO RN (UNII: AG9 B6 5PV6 B)
STEA RIC A CID (UNII: 4ELV7Z6 5AP)
VA NILLIN (UNII: CHI530 446 X)
PRODUCT CHARACTERISTICS
COLOR
PINK (pink-speckled white)
S CORE
no sco re
S HAP E
OVAL (Ovalo id)
S IZ E
19 mm
FLAVOR
IMPRINT CODE
PCE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:0 0 51-6 29 0 -0 4
6 0 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct
10 /0 5/20 11
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
Appro ved Drug Pro duct Manufactured Under
Co ntra c t
NDA0 50 6 11
10 /0 5/20 11
ERYTHROMYCIN
erythromycin tablet
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:0 0 51-338 9
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NA